Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Pediatr Infect Dis J
    February 2026
  1. KANG CR, Kim CB, Choe YJ, Kang IS, et al
    Emergence of Non-vaccine Serotypes and Antibiotic Resistance in Pneumococcal Carriage Among Korean Children: A Cross-sectional Study.
    Pediatr Infect Dis J. 2026 Feb 27. doi: 10.1097/INF.0000000000005206.
    >> Share

  2. ZHANG X, Balasubramani GK, D'Agostino HEA, Liu H, et al
    The Impact of Maternal Influenza Infection and Vaccination During Pregnancy on Birth Outcomes.
    Pediatr Infect Dis J. 2026 Feb 25. doi: 10.1097/INF.0000000000005194.
    >> Share

  3. QIU L, Pan H, Liang Q, Chen Z, et al
    Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.
    Pediatr Infect Dis J. 2026 Feb 18. doi: 10.1097/INF.0000000000005184.
    >> Share

  4. PLOTKIN SA
    Evidence for the Effectiveness of COVID-19 Vaccine in Children.
    Pediatr Infect Dis J. 2026 Feb 11. doi: 10.1097/INF.0000000000005157.
    >> Share

  5. SAEZ-LLORENS X, DeAntonio R
    Recent Advances in Dengue Vaccines for Children: Current Evidence and Future Directions.
    Pediatr Infect Dis J. 2026 Feb 2. doi: 10.1097/INF.0000000000005172.
    >> Share

  6. IZU A, Koen A, Jose L, Cutland C, et al
    Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.
    Pediatr Infect Dis J. 2026;45:173-180.
    >> Share

    January 2026
  7. MASSA JD, Giganti MJ, Lindsey JC, Levin MJ, et al
    Body Mass Index and Vaccine-induced Immune Responses in Children Living With HIV.
    Pediatr Infect Dis J. 2026 Jan 28. doi: 10.1097/INF.0000000000005153.
    >> Share

  8. LI X, Wang W, Kang X, Hu P, et al
    Vaccine Effectiveness and Clinical Characteristics of Breakthrough Varicella During Outbreaks Among Students in Qingdao, China.
    Pediatr Infect Dis J. 2026 Jan 7. doi: 10.1097/INF.0000000000005133.
    >> Share

  9. SUTCLIFFE CG, Sergent VM, Azarian T, Becenti LR, et al
    Pneumococcal Carriage Among Indigenous Children in the Southwest United States in 2022-2023.
    Pediatr Infect Dis J. 2026;45:89-95.
    >> Share

    December 2025
  10. HOMAIRA N, Qian J, Scaria A, Stepien S, et al
    Effectiveness of Maternal Influenza Vaccination on Influenza and Acute Respiratory Infection in Infants.
    Pediatr Infect Dis J. 2025 Dec 23. doi: 10.1097/INF.0000000000005111.
    >> Share

  11. HERNAN MA, Alvaro-Meca A, Calvo-Alcantara MJ, Navarro Gomez ML, et al
    Effectiveness and Safety of COVID-19 mRNA Vaccines in Children 6-17 Years Old: A Population-Based Study in Madrid.
    Pediatr Infect Dis J. 2025 Dec 16. doi: 10.1097/INF.0000000000005109.
    >> Share

  12. TAGARRO A, Gastesi I, Hotterbeekx A, Aguilera-Alonso D, et al
    Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine.
    Pediatr Infect Dis J. 2025 Dec 5. doi: 10.1097/INF.0000000000005042.
    >> Share

  13. MARLOW R, Roderick M, Oliver J, Jordan Z, et al
    Quality of Life Impact of Varicella on Children and Their Families in the UK: The QoLPoX Study.
    Pediatr Infect Dis J. 2025;44:1244-1249.
    >> Share

    November 2025
  14. PEREZ-LATORRE L, Cohen SH, Sanchez PJ, De Antonio R, et al
    SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer.
    Pediatr Infect Dis J. 2025 Nov 20. doi: 10.1097/INF.0000000000005032.
    >> Share

  15. OGIMI C, Ikuse T, Aizawa Y, Takanashi S, et al
    Current Challenges and Future Directions for RSV Prevention Strategies in Japan.
    Pediatr Infect Dis J. 2025;44:e400-e406.
    >> Share

    October 2025
  16. PLOTKIN SA
    Can We Have Better Influenza Vaccines?
    Pediatr Infect Dis J. 2025 Oct 17. doi: 10.1097/INF.0000000000005022.
    >> Share

    September 2025
  17. HOMINAL A, Gualtieri R, Lemaitre B, Posfay-Barbe KM, et al
    Vaccine Immunity Against Pneumococcus in Children With Cochlear Implants.
    Pediatr Infect Dis J. 2025 Sep 26. doi: 10.1097/INF.0000000000004999.
    >> Share

  18. KASAI S, Nagata M, Toyama Y, Inage E, et al
    Emerging Invasive Haemophilus influenzae Type C Infection in a Hib-vaccinated Child: Implications for Surveillance.
    Pediatr Infect Dis J. 2025 Sep 18. doi: 10.1097/INF.0000000000005011.
    >> Share

  19. AGARWAL A, Rana S, Mathur SB, Manchanda V, et al
    Immunogenicity of Three-session Intradermal Rabies Post-exposure Prophylaxis in Indian Children and Adolescents.
    Pediatr Infect Dis J. 2025 Sep 17. doi: 10.1097/INF.0000000000005004.
    >> Share

  20. LAZARO-MARTIN B, Tarancon-Diez L, Camino Lopez M, Alonso R, et al
    A Prospective Cohort Study of Hepatitis B Virus Vaccination in Pediatric Heart Transplant Recipients: Cellular and Humoral Immune Responses and the Role of Innate Immunity.
    Pediatr Infect Dis J. 2025 Sep 11. doi: 10.1097/INF.0000000000004958.
    >> Share

    August 2025
  21. NOBLE C, Gualtieri R, Mattiello V, Cimasoni L, et al
    Vaccine Immunity Against Pneumococcus in Children With Sickle Cell Disease: A Retrospective Single-center Study.
    Pediatr Infect Dis J. 2025 Aug 29. doi: 10.1097/INF.0000000000004947.
    >> Share

  22. GWAK E, Choe SA, Kim K, Bolormaa E, et al
    Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents.
    Pediatr Infect Dis J. 2025 Aug 27. doi: 10.1097/INF.0000000000004954.
    >> Share

  23. MA P, Chen PD, Jadhav S, He LL, et al
    Longitudinal Antibody Responses to SARS-CoV-2 Infection in Children: Impact of Age, Vaccines and Symptoms.
    Pediatr Infect Dis J. 2025 Aug 26. doi: 10.1097/INF.0000000000004949.
    >> Share

  24. PICHON S, Ullery GM, Cousin L, Sadarangani M, et al
    Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants.
    Pediatr Infect Dis J. 2025 Aug 15. doi: 10.1097/INF.0000000000004913.
    >> Share

  25. LUAN G, Zhang W, Cheng Y, Liu Y, et al
    Temporal Trends and Regional Disparities in Rotavirus Vaccine Coverage for Children Under 1-Year-old in Shandong Province, China.
    Pediatr Infect Dis J. 2025 Aug 13. doi: 10.1097/INF.0000000000004953.
    >> Share

    June 2025
  26. CALLAGHAN T, Wise LA, Regan AK
    Intention to Use RSVpreF Vaccine or Nirsevimab to Prevent Infant RSV Among Pregnant Individuals.
    Pediatr Infect Dis J. 2025 Jun 3. doi: 10.1097/INF.0000000000004889.
    >> Share

  27. FAFI I, Cohen R, Levy C, Varon E, et al
    High Mortality Due to Pneumococcal Meningitis in Children With Sickle Cell Disease: A French Multicenter Observational Study From 2001 to 2021.
    Pediatr Infect Dis J. 2025;44:496-502.
    >> Share

  28. TOP KA, Shulha HP, Hassan F, Sauve L, et al
    Epidemiology of Febrile Seizures During the Covid-19 Pandemic: A Canadian Immunization Monitoring Program-Active (IMPACT) Study.
    Pediatr Infect Dis J. 2025;44:e230-e233.
    >> Share

    May 2025
  29. GENTILE A, Juarez MDV, Lucion MF, Gregorio G, et al
    Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus-associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case-control Study.
    Pediatr Infect Dis J. 2025 May 28. doi: 10.1097/INF.0000000000004878.
    >> Share

  30. PLOTKIN SA
    Bring Back Vaccinia!
    Pediatr Infect Dis J. 2025 May 21. doi: 10.1097/INF.0000000000004863.
    >> Share

  31. LOEVE LF, Sideridou VL, Scholvinck EH, Brandsema RB, et al
    A CASE OF CONGENITAL RUBELLA SYNDROME IN THE NETHERLANDS: A Brief Report on Rubella Virus Surveillance.
    Pediatr Infect Dis J. 2025 May 21. doi: 10.1097/INF.0000000000004849.
    >> Share

    April 2025
  32. ARRIETA AC, Osborne S, Grant LR, Gessner BD, et al
    Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis.
    Pediatr Infect Dis J. 2025 Apr 21. doi: 10.1097/INF.0000000000004833.
    >> Share

  33. CAVALCANTE LRL, Los DB, Fiorenza NG, Kehdi RC, et al
    Maternal Immunization Against SARS-CoV-2 and Infant Immunity Persistence in a Brazilian Cohort.
    Pediatr Infect Dis J. 2025 Apr 9. doi: 10.1097/INF.0000000000004817.
    >> Share

  34. BUTIC I, Tesovic G, Bodulic K, Lucic S, et al
    Impact of Universal PCV10 Vaccination on Invasive Pneumococcal Disease in Croatian Children.
    Pediatr Infect Dis J. 2025 Apr 8. doi: 10.1097/INF.0000000000004821.
    >> Share

    March 2025
  35. FALLACH N, Lasalvia P, Pawaskar M, Chodick G, et al
    Impact of Universal Varicella Vaccination in Israel: A Time-Series Analysis, 2003 to 2020.
    Pediatr Infect Dis J. 2025 Mar 19. doi: 10.1097/INF.0000000000004787.
    >> Share

  36. MCALISTER SM, van den Biggelaar AHJ, Cooper MN, Thornton R, et al
    Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses.
    Pediatr Infect Dis J. 2025 Mar 5. doi: 10.1097/INF.0000000000004764.
    >> Share

  37. EGESKOV-CAVLING AM, Johannesen CK, Folke F, Fischer TK, et al
    Evaluating the Impact of Moderate and Severe Varicella Infections on Danish Children Under 18 Years Old: A Comprehensive Analysis From 2015 to 2023.
    Pediatr Infect Dis J. 2025;44:270-276.
    >> Share

    February 2025
  38. ISLAM K, Sancho-Shimizu V, Kampmann B, Diavatopoulos D, et al
    Heterologous Effects of Pertussis and Influenza Vaccines During Pregnancy on Maternal and Infant Innate Immune Responses: A Pilot Study.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  39. DANIEL O, Loughnan M, Quenby M, Chawla K, et al
    Antibody in Breastmilk Following Pertussis Vaccination in Three-time Windows in Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  40. CASTRELLON PARDO M, Bruce M, Surti MS, Myers-Stewart M, et al
    A Qualitative, Patient-led Exploration of Vaccination Communication Preferences Among a Diverse Sample of Pregnant, Postpartum, Breastfeeding Canadians.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  41. KUNTZ JL, Babu TM, Feldstein LR, Englund JA, et al
    Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  42. PAULSON S, Munro APS, Cathie K, Bedford H, et al
    Protecting Against Respiratory Syncytial Virus: An Online Questionnaire Study Exploring UK Parents' Acceptability of Vaccination in Pregnancy or Monoclonal Antibody Administration for Infants.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  43. SOSA M, Haghighi C, Pike M, Stolarczuk JE, et al
    Perception of a Novel Group B Streptococcus Vaccine Among Pregnant and Lactating Individuals.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  44. KYOHERE M, Nalubega P, Ssemere H, Ssali A, et al
    Increasing Maternal Vaccination Awareness, by Working With Women Influencers in Kawempe Division, Uganda: A Brief Report.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  45. DE BRABANDERE L, Hanning N, Hendrickx G, Van Damme P, et al
    Vaccine Confidence During Pregnancy and the Impact of the COVID-19 Pandemic: A Wide Variety of Views Across the European Union.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  46. QUINCER EM, Gobezayehu AG, Belew ML, Endalamaw LA, et al
    High Intention to Vaccinate Against Tuberculosis During Pregnancy and Lactation: Understanding Vaccine-specific Maternal Immunization Acceptance in Amhara, Ethiopia.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  47. NAMBASA VP, Ssebagereka A, Ssali A, Namugumya R, et al
    Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  48. NYIRO JU, Bukusi E, Mureithi MW, Walumbe D, et al
    Prevalence and Predictors of Adverse Birth Outcomes and Their Implications in Assessing the Safety of New Maternal Vaccines in Kenya.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  49. BERRUETA M, Ciapponi A, Bardach A, Ballivan J, et al
    Safe in Pregnancy and Safe in Children: Global Living Systematic Reviews and Meta-analyses Hub for Emergency Vaccines.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  50. REGAN AK, Rowe SL
    Use of Routinely Collected "Real-world" Data for the Postlicensure Safety Assessment of Vaccination During Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  51. NALEWAY AL, Crane B, Irving SA, Daley MF, et al
    Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  52. NOGUCHI L, Njogu R, Morgan C, Yunus S, et al
    Facility Readiness Assessment for Maternal Immunization: Results of Field Testing in Kenya and Bangladesh.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  53. MOURAO ML, Baca-Arzaga A, Castellanos M, Johnstone R, et al
    Trends in Neonatal Vaccination: A Ten-year Retrospective Study in a Large Delivery Center.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  54. STURROCK S, Davies H, Rukundo G, Komugisha C, et al
    Sociodemographic Factors Associated With Established and Novel Antenatal Vaccination Uptake in a Cohort of Pregnant Women in Uganda.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  55. PALADINO B, Delfino M, Badia F, Pujadas M, et al
    Assessing Vaccine Coverage and Barriers to Immunization Among Pregnant Individuals in Uruguay: A Brief Report.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  56. BOURNE J, Sawry S, Le Roux J, Fairlie L, et al
    Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  57. GENTILE A, Castellano VE, Ulloa-Gutierrez R, Duenas L, et al
    Pertussis Vaccination During Pregnancy: Regional Situation and Impact of Implementation on National Immunization Programs in Latin America.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  58. MASSORA S, Mucavele H, Carvalho MDG, Mandomando I, et al
    Effect of the Ten-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease and Pneumonia in Infants Younger Than Ten Weeks of Age in Southern Mozambique: A Population-based Prospective Surveillance Study.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  59. PUTHANAKIT T, Chokephaibulkit K, Anugulruengkitt S, Chaithongwongwatthana S, et al
    Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  60. SASO A, Kampmann B
    What Is the Impact of Maternal Pertussis Immunization in Pregnancy on the Quantity, Quality and Longevity of Infant Vaccine Responses?: A Review of the Current Evidence.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  61. KUNG S, Pike M, Eckert LO, Cheu LA, et al
    Comparative Analysis of Transplacental SARS-CoV-2 Antibody Transfer in Pregnancy Phenotypes With Pre-eclampsia and/or Small-for-gestational-age Infants.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  62. DEESE J, Schaible K, Massierer D, Tingir N, et al
    Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation: Tetanus, Pertussis, Influenza and COVID-19.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  63. STURROCK S, Cavell B, Alexander F, Apostolakis K, et al
    Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  64. BALLIVIAN J, Parker EPK, Berrueta M, Ciapponi A, et al
    Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  65. GENTILE A, Juarez MDV, Lucion MF, Ensinck G, et al
    Respiratory Syncytial Virus Epidemiology in Argentina: From COVID-19 Pandemic to the Maternal Immunization Strategy.
    Pediatr Infect Dis J. 2025;44.
    >> Share

  66. FAY K, Groome MJ, Barsosio H, Seale AC, et al
    How Can We Accelerate Maternal Vaccination Globally?
    Pediatr Infect Dis J. 2025;44.
    >> Share

  67. KAMPMANN B, Jones CE, Faber H
    Immunizing Pregnant Women and Infants (IMPRINT) Network: Building and Sustaining an Interdisciplinary Network Tackling the Complex Challenges of Vaccination in Pregnancy and Early Life.
    Pediatr Infect Dis J. 2025;44.
    >> Share

    January 2025
  68. HAN MS, Choi S, Yoon Y, Kim YK, et al
    Long-Term Response to SARS-CoV-2 mRNA Vaccine in Adolescents.
    Pediatr Infect Dis J. 2025 Jan 28. doi: 10.1097/INF.0000000000004709.
    >> Share

  69. LEVY C, Varon E, Bechet S, Bonacorsi S, et al
    Similarities and Differences Between Countries When Estimating the Effect of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media.
    Pediatr Infect Dis J. 2025 Jan 21. doi: 10.1097/INF.0000000000004686.
    >> Share

  70. TACHIKAWA J, Aizawa Y, Ikuse T, Yamanaka T, et al
    Clinical Characteristics of Hospitalized Children With Coronavirus Disease 2019 After the Spread of the BA.5 Omicron Variants in Japan.
    Pediatr Infect Dis J. 2025;44:665-671.
    >> Share

  71. HAMILTON K, Luvsansharav UO, Xing W, Gierke R, et al
    Characteristics of Invasive Pneumococcal Diseases Cases Among U.S. Children With Hematologic Malignancies Before and After Introduction of Thirteen-valent Pneumococcal Conjugate Vaccine, 2005-2019.
    Pediatr Infect Dis J. 2025 Jan 17. doi: 10.1097/INF.0000000000004730.
    >> Share

  72. YEE JS, Doyle R, Wen SC
    Improved Uptake of Vaccinations in Children With Adverse Events Following Immunization After Specialist Immunization Service Intervention in an Australian Pediatric Hospital.
    Pediatr Infect Dis J. 2025 Jan 7. doi: 10.1097/INF.0000000000004719.
    >> Share

  73. PLOTKIN SA
    Do We Need a Lyme Disease Vaccine?
    Pediatr Infect Dis J. 2025;44:32.
    >> Share

  74. BURTON C, Webb R, Anglemyer A, Humphrey A, et al
    Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in Tamaki Makaurau Auckland, Aotearoa New Zealand.
    Pediatr Infect Dis J. 2025;44:90-96.
    >> Share

    November 2024
  75. MUNOZ FM, Beigi R, Posavad CM, Kelly C, et al
    Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
    Pediatr Infect Dis J. 2024;43:1065-1073.
    >> Share

  76. OLARTE L, Banerjee D, Swanson D, Tabakh J, et al
    Pneumococcal Colonization in Children With Persistent Asthma: A Retrospective Cohort.
    Pediatr Infect Dis J. 2024;43:1033-1039.
    >> Share

    October 2024
  77. OHNISHI T, Erdem G, Kuno T, Yasuhara J, et al
    mRNA Vaccines: Future Perspectives for Children.
    Pediatr Infect Dis J. 2024 Oct 8. doi: 10.1097/INF.0000000000004557.
    >> Share

  78. TOIZUMI M, Takamatsu M, Toda K, Horikoshi Y, et al
    Progresses Toward Polio Eradication in Asian Countries: Its History and Japan's Contributions.
    Pediatr Infect Dis J. 2024;43:e347-e353.
    >> Share

    September 2024
  79. PLOTKIN SA
    Why Combination Vaccines Are Necessary.
    Pediatr Infect Dis J. 2024 Sep 18. doi: 10.1097/INF.0000000000004476.
    >> Share

  80. DINLEYICI EC, Kurugol Z, Devrim I, Bayram N, et al
    Pediatric Varicella-related Hospitalization in Turkey Between 2008 and 2018: Impact of Universal Single Dose Varicella Vaccine (VARICOMP Study).
    Pediatr Infect Dis J. 2024 Sep 4. doi: 10.1097/INF.0000000000004521.
    >> Share

  81. OLUWASEUN S, Cagnan L, Xausa I, Nachbar RB, et al
    Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Pediatr Infect Dis J. 2024;43:902-908.
    >> Share

  82. PLOTKIN SA
    Multiple Questions About Protection From Respiratory Syncytial Virus.
    Pediatr Infect Dis J. 2024;43:867-868.
    >> Share

  83. KUS S, Elvan-Tuz A, Aslan-Saritas U, Yilmaz D, et al
    Brain Abscess Developing After Lobar Pneumonia: A Rare Complication in Unvaccinated Child Caused by Streptococcus pneumoniae Serotype 14.
    Pediatr Infect Dis J. 2024;43:e338-e339.
    >> Share

    August 2024
  84. BURGESS C, Lisul B, Pawaskar M, Petigara T, et al
    Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-Up Efforts for Serbia.
    Pediatr Infect Dis J. 2024 Aug 2. doi: 10.1097/INF.0000000000004487.
    >> Share

    July 2024
  85. KOBBE R, Rau C, Schulze-Sturm U, Stahl F, et al
    Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children.
    Pediatr Infect Dis J. 2024 Jul 30. doi: 10.1097/INF.0000000000004488.
    >> Share

  86. LEE ES, Choe YJ, Choe SA, Gwak ES, et al
    Relative Effectiveness of the NVX-CoV2373 Vaccine Compared With the BNT162b2 Vaccine in Adolescents.
    Pediatr Infect Dis J. 2024 Jul 3. doi: 10.1097/INF.0000000000004463.
    >> Share

  87. XIAO G, Zhu T, Wang Z, Xie X, et al
    Pentavalent Rotavirus Vaccine Coverage and Trends in Rotavirus Detection Before and After This Vaccination in Chengdu, China.
    Pediatr Infect Dis J. 2024 Jul 2. doi: 10.1097/INF.0000000000004441.
    >> Share

    June 2024
  88. OLUWASEUN S, Cagnan L, Xausa I, Nachbar RB, et al
    Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Pediatr Infect Dis J. 2024 Jun 25. doi: 10.1097/INF.0000000000004448.
    >> Share

  89. DEMIRBUGA A, Keskindemir G, Onal Z, Dede E, et al
    Bacillus Calmette-Guerin Vaccine-associated Complications in Immunodeficient Patients Following Liver Transplantation.
    Pediatr Infect Dis J. 2024 Jun 25. doi: 10.1097/INF.0000000000004456.
    >> Share

  90. SOONTHORNARRAK K, Limrungsikul A, Apiwattanakul N
    Comparison of Hepatitis B Surface Antibody Levels After Vaccination With Combined One Dose of Hexavalent Vaccine and Two Doses of Pentavalent Vaccine Versus Three Doses of Pentavalent Vaccine.
    Pediatr Infect Dis J. 2024 Jun 24. doi: 10.1097/INF.0000000000004449.
    >> Share

  91. KAUR R, Schulz S, Sherman A, Andrejko K, et al
    Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media.
    Pediatr Infect Dis J. 2024 Jun 5. doi: 10.1097/INF.0000000000004413.
    >> Share

  92. BANDYOPADHYAY AS, Burke RM, Hawes KM
    Polio Eradication: Status, Struggles and Strategies.
    Pediatr Infect Dis J. 2024;43:e207-e211.
    >> Share

    May 2024
  93. MAYTUM A, Porter D, de Whalley P, Thompson A, et al
    The Impact of Infant Bacille Calmette-Guerin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
    Pediatr Infect Dis J. 2024 May 8. doi: 10.1097/INF.0000000000004373.
    >> Share

  94. LIN W, Wang B, Wang M, Wang Y, et al
    The Unneglectable Disease Burden of Otitis Media Among Children in China: A Systematic Review and Meta-analysis.
    Pediatr Infect Dis J. 2024;43:403-409.
    >> Share

    April 2024
  95. PLOTKIN SA
    We Need a New Mumps Vaccine.
    Pediatr Infect Dis J. 2024;43:350.
    >> Share

    March 2024
  96. SENDERS S, Klein NP, Tamimi N, Thompson A, et al
    A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004334.
    >> Share

  97. PLOTKIN SA, Offit P
    Efficacy of Rotavirus Vaccines.
    Pediatr Infect Dis J. 2024 Mar 20. doi: 10.1097/INF.0000000000004319.
    >> Share

  98. MEYER J, Silas P, Ouedraogo GL, McElwee K, et al
    A Phase 3, Single-Arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
    Pediatr Infect Dis J. 2024 Mar 15. doi: 10.1097/INF.0000000000004318.
    >> Share

  99. MAROM T, Ovnat Tamir S
    Pediatric Otitis Media in the New Pneumococcal Conjugate Vaccines Era: What's Next?
    Pediatr Infect Dis J. 2024 Mar 15. doi: 10.1097/INF.0000000000004323.
    >> Share

  100. KORBAL P, Wysocki J, Jackowska T, Kline M, et al
    Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.
    Pediatr Infect Dis J. 2024 Mar 8. doi: 10.1097/INF.0000000000004300.
    >> Share

    February 2024

  101. Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared With Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance: ERRATUM.
    Pediatr Infect Dis J. 2024;43:186.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016